Aldeyra Therapeutics (ALDX)

Aldeyra Therapeutics (ALDX) Financial Statements


Aldeyra Therapeutics Financial Overview

Aldeyra Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.039; its P/E ratio is -10.24; Aldeyra Therapeutics is scheduled to report earnings on August 10, 2023, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -16.80M$ -13.70M$ -14.14M$ -17.37M$ -16.38M
EBITDA$ -16.66M-$ -14.07M$ -17.31M$ -16.32M
Net Income Common Stockholders$ -15.62M$ -12.90M$ -14.55M$ -17.78M$ -16.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 29.88M$ 185.33M$ 196.69M$ 216.87M
Total Assets$ 168.21M$ 181.27M$ 189.69M$ 201.02M$ 222.69M
Total Debt$ 16.11M$ 16.08M$ 15.94M$ 15.91M$ 15.89M
Net Debt$ 16.11M$ -13.80M$ -169.39M$ -180.78M$ -200.98M
Total Liabilities$ 30.98M$ 181.29M$ 27.50M$ 26.99M$ 32.00M
Stockholders Equity$ 137.24M$ 151.01M$ 162.19M$ 174.03M$ 190.69M
Cash Flow-
Free Cash Flow$ -9.44M$ -11.23M$ -12.57M$ -19.96M$ -12.89M
Operating Cash Flow$ -9.44M$ -11.23M$ -12.57M$ -19.96M$ -12.87M
Investing Cash Flow$ 30.00M$ 27.00M$ 19.02M$ -17.94M$ -58.03M
Financing Cash Flow$ 52.56K-$ 1.20M$ 0.00$ 23.32K
Currency in USD

Aldeyra Therapeutics Earnings and Revenue History

Aldeyra Therapeutics Debt to Assets

Aldeyra Therapeutics Cash Flow

Aldeyra Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis